Korean Drug Co., Ltd. (KOSDAQ:014570)
4,645.00
+35.00 (0.76%)
At close: Sep 18, 2025
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 50.52 billion as of September 19, 2025. Its market cap has decreased by -13.62% in one year.
Market Cap
50.52B
Enterprise Value
25.28B
Revenue
62.74B
Ranking
n/a
PE Ratio
14.10
Stock Price
4,645.00
Market Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 50.52B, an increase of 302.89%. That is a compound annual growth rate of 7.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 50.52B | 0.76% |
Dec 30, 2024 | 50.14B | -36.00% |
Dec 28, 2023 | 78.35B | -8.30% |
Dec 29, 2022 | 85.44B | -12.32% |
Dec 30, 2021 | 97.44B | -13.30% |
Dec 30, 2020 | 112.39B | 43.25% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 520.34T |
SK hynix | 243.72T |
LG Energy Solution | 81.78T |
Samsung Biologics | 72.88T |
Hanwha Aerospace | 52.58T |
Hyundai Motor Company | 46.74T |
HD Hyundai Heavy Industries | 43.77T |
KB Financial Group | 42.75T |